M Kuželová

553 total citations
43 papers, 424 citations indexed

About

M Kuželová is a scholar working on Geriatrics and Gerontology, Cardiology and Cardiovascular Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, M Kuželová has authored 43 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Geriatrics and Gerontology, 9 papers in Cardiology and Cardiovascular Medicine and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in M Kuželová's work include Pharmaceutical Practices and Patient Outcomes (11 papers), Pharmaceutical studies and practices (8 papers) and Blood Pressure and Hypertension Studies (5 papers). M Kuželová is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (11 papers), Pharmaceutical studies and practices (8 papers) and Blood Pressure and Hypertension Studies (5 papers). M Kuželová collaborates with scholars based in Slovakia, Czechia and Sweden. M Kuželová's co-authors include Martin Wawruch, Ladislava Wsólová, Adriana Adameová, Elena Ondriašová, Viera Kristová, Andrej Dukát, Ján Murín, Petr Švec, J. Luha and Daniela Ježová and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecules and European Journal of Pharmacology.

In The Last Decade

M Kuželová

40 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Kuželová Slovakia 12 183 108 93 70 65 43 424
Encarnación Blanco‐Reina Spain 14 195 1.1× 94 0.9× 87 0.9× 79 1.1× 84 1.3× 32 620
Dana G. Carroll United States 12 156 0.9× 63 0.6× 59 0.6× 43 0.6× 46 0.7× 38 597
Teodoro J. Oscanoa Peru 9 224 1.2× 57 0.5× 79 0.8× 50 0.7× 37 0.6× 63 493
Martin Wawruch Slovakia 15 198 1.1× 141 1.3× 82 0.9× 109 1.6× 45 0.7× 65 604
Karolina Antonov Sweden 13 256 1.4× 56 0.5× 90 1.0× 123 1.8× 100 1.5× 16 569
Charles D. Peterson United States 17 154 0.8× 65 0.6× 52 0.6× 48 0.7× 106 1.6× 37 767
Henk Buurma Netherlands 16 409 2.2× 75 0.7× 144 1.5× 133 1.9× 74 1.1× 30 727
C. Rajkumar United Kingdom 10 136 0.7× 125 1.2× 40 0.4× 38 0.5× 39 0.6× 24 409
Olga Laosa Spain 12 232 1.3× 47 0.4× 66 0.7× 122 1.7× 50 0.8× 21 675
Saied Eslami Netherlands 8 251 1.4× 84 0.8× 60 0.6× 81 1.2× 65 1.0× 12 563

Countries citing papers authored by M Kuželová

Since Specialization
Citations

This map shows the geographic impact of M Kuželová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Kuželová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Kuželová more than expected).

Fields of papers citing papers by M Kuželová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Kuželová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Kuželová. The network helps show where M Kuželová may publish in the future.

Co-authorship network of co-authors of M Kuželová

This figure shows the co-authorship network connecting the top 25 collaborators of M Kuželová. A scholar is included among the top collaborators of M Kuželová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Kuželová. M Kuželová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuželová, M, et al.. (2019). Is gentamicin administered to individual patients in optimal doses already at the beginning of therapy?. SHILAP Revista de lepidopterología. 66(1). 11–18. 1 indexed citations
2.
Kuželová, M, et al.. (2018). Relationship between adolescents’ and their parents’ attitudes toward medicines and awareness of the risk of medicines. International Journal of Clinical Pharmacy. 40(6). 1501–1510. 2 indexed citations
3.
Kuželová, M, et al.. (2017). Identifying the interprofessional agreement between community pharmacist's and general practitioner's views on collaborative practice in Slovakia. Česká a slovenská farmacie. 66(2). 67–75. 1 indexed citations
4.
5.
Kuželová, M, et al.. (2016). Development and validation of novel self-report questionnaire about the assessment of adolescents’ relation to medicines use and risk. SHILAP Revista de lepidopterología. 63(1). 33–35. 1 indexed citations
6.
Wawruch, Martin, et al.. (2015). The use of antiplatelet medication in hospitalised elderly patients. Bratislavské lekárske listy/Bratislava medical journal. 116(9). 533–538. 3 indexed citations
7.
8.
Wawruch, Martin, et al.. (2014). Influence of hospitalisation on the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in elderly hypertensive patients. Aging Clinical and Experimental Research. 26(3). 307–314. 1 indexed citations
9.
Kuželová, M, et al.. (2012). Pharmacotherapeutic adherence and quality of life in paediatric outpatients with epilepsy. 59(Supplement-VI). 76–83. 3 indexed citations
10.
Švec, Peter & M Kuželová. (2012). 35 years of education in clinical pharmacology at the Faculty of Pharmacy in Comenius University. 59(Supplement-VI). 67–75.
11.
Wawruch, Martin, M Kuželová, Elena Ondriašová, et al.. (2012). Characteristics of elderly patients who consider over-the-counter medications as safe. International Journal of Clinical Pharmacy. 35(1). 121–128. 19 indexed citations
12.
Adameová, Adriana, D Pancza, M Kuželová, et al.. (2009). Simvastatin alleviates myocardial contractile dysfunction and lethal ischemic injury in rat heart independent of cholesterol-lowering effects. Physiological Research. 58(3). 449–454. 29 indexed citations
13.
Wawruch, Martin, et al.. (2008). Adverse drug reactions related to hospital admission in Slovak elderly patients. Archives of Gerontology and Geriatrics. 48(2). 186–190. 30 indexed citations
14.
Wawruch, Martin, Daniela Fialová, Ladislava Wsólová, et al.. (2008). Factors influencing the use of potentially inappropriate medication in older patients in Slovakia. Journal of Clinical Pharmacy and Therapeutics. 33(4). 381–392. 39 indexed citations
15.
Adameová, Adriana, et al.. (2008). Effects of Ligustrum delavayanum Hariot. on cholesterol levels and arrhythmogenesis induced by myocardial ischaemia–reperfusion injury in diabetic-hypercholesterolaemic rats. Environmental Toxicology and Pharmacology. 26(2). 255–258. 1 indexed citations
16.
Kotaška, Karel, et al.. (2008). Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin. Journal of Clinical Pharmacy and Therapeutics. 33(4). 409–417. 18 indexed citations
17.
Kuželová, M, et al.. (2006). NO-synthase inhibitors provide influence on protective effect of modified endotoxine diphosphoryl lipid A in a rat heart model of ischemic-reperfusion injury.. PubMed. 61(6). 568–70. 3 indexed citations
18.
Wawruch, Martin, Ladislava Wsólová, Daniela Ježová, et al.. (2006). Perception of potentially inappropriate medication in elderly patients by Slovak physicians. Pharmacoepidemiology and Drug Safety. 15(11). 829–834. 16 indexed citations
19.
Čepický, P, et al.. (2003). [Treatment of aerobic vaginitis and clinically uncertain causes of vulvovaginal discomfort].. PubMed. 68(6). 439–42. 2 indexed citations
20.
Kuželová, M, et al.. (1993). [Development of a withdrawal syndrome in a neonate after long-term therapy of the mother with metipranolol during pregnancy].. PubMed. 48(10). 608–10.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Encarnación Blanco‐Reina Breakdown of academic impact, for papers by Dana G. Carroll Breakdown of academic impact, for papers by Teodoro J. Oscanoa Breakdown of academic impact, for papers by Martin Wawruch Breakdown of academic impact, for papers by Karolina Antonov Breakdown of academic impact, for papers by Charles D. Peterson Breakdown of academic impact, for papers by Henk Buurma Breakdown of academic impact, for papers by C. Rajkumar Breakdown of academic impact, for papers by Olga Laosa Breakdown of academic impact, for papers by Saied Eslami
Rankless by CCL
2026